Antitumor activity
• volume tumor
• % of surviving mice
of ZD-1839 on established GEO human colon carcinoma xenographs: effet dose
RECEPTOR TYROSINE KINASE INHIBITORS
ACTIVITY - ZD 1839
Ciardiello et al (2000) Clin. Res. Cancer 6: 2053-2063
2003-2004